Placebos are reshaping what drug trials can prove

Something Weird Is Going On With Placebos

As placebo responses strengthen, especially in American painkiller trials, researchers face a harder question: how much benefit comes from the drug itself?

3 key takeaways

1Expectations, conditioning, care, and treatment rituals can alter pain and other symptoms without changing the underlying disease.
2Open-label placebos may help, but the urge to do something can also encourage unnecessary or risky medical intervention.
3Belief can create reassurance and control, yet perceived safety may reduce caution and make outcomes worse.

Don't miss

The hosts connect fake control devices, such as crossing buttons and office thermostats, to the deeper psychology of reassurance and agency.

The brief

Hannah Fry and Michael Stevens begin with a puzzle in modern medicine: placebo effects, particularly in American painkiller trials, appear to have grown stronger over time.

That trend narrows the measured gap between real drugs and inert treatments, forcing researchers to separate pharmacology from expectation, conditioning, care, and the ritual of treatment.

The hosts explain why beliefs can reshape pain and symptoms, while stressing that placebo effects have limits and cannot simply repair every underlying bodily process.

Open-label placebos and treatment rituals may provide useful reassurance, but the desire to feel active can also push patients toward unnecessary monitoring or intervention.

The episode’s wider turn is behavioral: fake crossing buttons and office controls can create agency, while perceived safety can reduce caution behind the wheel or elsewhere.

Nocebos and the Tinkerbell effect leave a sharper conclusion: belief can make care feel effective, institutions seem real, and confidence itself become a source of risk.